![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
1. 446292-07-5
2. 2-[(2r)-2-hydroxy-3-[[4-(3-oxo-4-morpholinyl)phenyl]amino]propyl]-1h-isoindole-1,3(2h)-dione
3. 2-[(2r)-2-hydroxy-3-{[4-(3-oxomorpholin-4-yl)phenyl]amino}propyl]-1h-isoindole-1,3(2h)-dione
4. 2-[(2r)-2-hydroxy-3-[4-(3-oxomorpholin-4-yl)anilino]propyl]isoindole-1,3-dione
5. 1h-isoindole-1,3(2h)-dione,2-[(2r)-2-hydroxy-3-[[4-(3-oxo-4-morpholinyl)phenyl]amino]propyl]-
6. 2-((2r)-2-hydroxy-3-{[4-(3-oxo-4-morpholinyl)phenyl]amino}propyl)-1h-isoindole-1,3(2h)-dione
7. Ec 610-200-5
8. Schembl77318
9. Amy4159
10. Dtxsid10467923
11. Bcp27211
12. Cs-m0561
13. Mfcd11977664
14. Zinc65742968
15. Akos016007842
16. Ds-4456
17. 2-((2r)-2-hydroxy-3-((4-(3-oxo-4-morpholinyl) Phenyl)amino)propyl)-1h-isoindole-1,3(2h)-dione
18. Ac-25296
19. F12082
20. A854756
21. (r)-2-(2-hydroxy-3-((4-(3-oxomorpholino)phenyl)-amino)propyl)isoindoline-1,3-dione
22. (r)-2-(2-hydroxy-3-(4-(3-oxo-morpholino)phenylamino)propyl)isoindoline-1,3-dione
23. (r)-2-(2-hydroxy-3-(4-(3-oxomorpholino)phenylamino)propyl)isoindoline-1,3-dione
24. (r)-2-{2-hydroxy-3-[4-(3-oxo-morpholin-4-yl)-phenylamino]-propyl}-isoindole-1,3-dione
25. 2-{(2r)-2-hydroxy-3-[4-(3-oxomorpholin-4-yl)anilino]propyl}-1h-isoindole-1,3(2h)-dione
26. 2-{2(r)-hydroxy-3-[4-(3-oxo-morpholin-4-yl)phenyl Amino]-propyl}-isoindole-1,3-dione
27. (r)-2-(2-hydroxy-3-((4-(3-oxomorpholino)phenyl)amino)propyl)isoindoline-1,3-dione; 2-[(2r)-2-hydroxy-3-[[4-(3-oxo-4-morpholinyl)phenyl]amino]propyl]-1h-isoindole-1,3(2h)-dione
28. (r)-2-(2-hydroxy-3-{[4-(3-oxomorpholin-4-yl)phenyl]amino}propyl)-1h-isoindole-1,3(2h)-dione
29. 1h-isoindole-1,3(2h)-dione, 2-[(2r)-2-hydroxy-3-[[4-(3-oxo-4-morpholinyl)phenyl]amino]propyl]
30. 2((2r)-2-hydroxy-3-{[4-(3-oxo-4-morpholinyl)phenyl]amino}propyl)-1h-iso-indole-1,3(2h)-dione
31. 2-((2r)-2-hydroxy-3-{ [4-(3-oxo-4-morpholinyl)phenyl]amino}propyl)-1h-isoindole-1,3(2h)-dione
32. 2-((2r)-2-hydroxy-3-{[4-(3-oxo-4-morpholinyl)-phenyl]amino}propyl)-1h-isoindole-1,3(2h)dione
33. 2-((2r)-2-hydroxy-3-{[4-(3-oxo-4-morpholinyl)phenyl]amino}propyl)-1h-iso-indole-1,3(2h)-dione
34. 2-((2r)-2-hydroxy-3{[4-(3-oxo-4-morpholinyl)phenyl]amino}propyl)-1h-iso-indole-1,3(2h)-dione
35. 2-[(2r)-2-hydroxy-3-[[4-(3-oxo-4-morpholinyl)phenyl]-amino]propyl]-1h-isoindole-1,3(2h)-dione
36. 2-[(2r)-2-hydroxy-3-{[4(3-oxomorpholin-4-yl)phenyl]amino}propyl]-1h-isoindole-1,3(2h)-dione
37. 2-[(2r)-2-hydroxy-3-{[4-(3-oxo Morpholin-4-yl)phenyl]amino}propyl]-1h-isoindole-1,3(2h)-dione
Molecular Weight | 395.4 g/mol |
---|---|
Molecular Formula | C21H21N3O5 |
XLogP3 | 1 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 6 |
Exact Mass | 395.14812078 g/mol |
Monoisotopic Mass | 395.14812078 g/mol |
Topological Polar Surface Area | 99.2 Ų |
Heavy Atom Count | 29 |
Formal Charge | 0 |
Complexity | 610 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Note: None of the products will be supplied to countries in which this could be in conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer.
Note: None of the products will be supplied to countries in which this could be in conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer.
Note: None of the products will be supplied to countries in which this could be in conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer.
Note: None of the products will be supplied to countries in which this could be in conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer.